netFormulary Bradford Teaching Hospitals NHS
NHS Foundation Trust Formulary  
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
09.06.04  Expand sub section  Vitamin D
Alfacalcidol
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary  
   
Calcitriol
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary  
   
Colecalciferol
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Colecalciferol preparations supplied for treatment of deficency only

  • Plenchol 20,000 unit capsules
  • Thorens 10,000 unit/ml oral drops- for children and adults with swallowing difficulties
  • Maintenance doses (e.g. 1000 unit capsules) not stocked
 
   
Ergocalciferol
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary  
   
Paricalcitol
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary  
   
09.06.04  Expand sub section  Vitamin D with Calcium
Adcal D3
(Chewable tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
First Choice
Green
  • Colecalciferol 400 units (10 micrograms) + calcium carbonate 1500mg (calcium 600mg) per tablet
 
Adcal D3 Dissolve
(Effervescent tablets)
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Green
  • Colecalciferol 400 units + calcium carbonate 1500mg per tablet
  • For patients who cannot chew or swallow tablets or for giving via an enteral tube
 
   
Adcal D3 Caplets
(Film coated tablet)
View adult BNF View SPC online View childrens BNF  Track Changes
Second Choice
Green
  • Colecalciferol 200 units (5 micrograms) + calcium carbonate 750mg (calcium 300mg) per caplet
  • For patients who cannot tolerate Adcal D3 chewable tablets but can swallow tablets
 
   
 ....
 Non Formulary Items
Calcitriol  (Calcijex®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Calcitriol  (Rocaltrol®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Calcium and Ergocalciferol

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Calcium Carbonate with Colecalciferol  (Cacit D3)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol  (Accrete D3®)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
 
Colecalciferol  (Adcal-D3®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol  (Kalcipos-D®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol 1,000 units  (Sunvit D3)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol 20,000 units  (Pro D3, Dekristol)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol 3,000 units per ml liquid

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol 800 units  (Desunin)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol and Calcium Carbonate  (Adcal-D3)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol and Calcium Carbonate  (Calcichew-D3)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Colecalciferol and Calcium Carbonate  (Calcichew-D3 Forte)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Dihydrotachysterol  (AT 10®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ergocalciferol  (Calceos®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Ergocalciferol  (Calfovit D3)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Medicines suitable to be prescribed in primary care after Specialist* recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust D&TC(s). *Specialist is defined as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice.   

Amber 1

Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (D&TC) * All drugs awaiting the production or approval of a shared care guideline default to RED   

Cancer Drug Fund

Cancer Drug Fund   

Green

Medicines suitable for routine use and can be prescribed within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.  

Green Specialist Initiation

These drugs should be initiated only by a hospital or specialist clinician (GPSi) but there is no requirement for additional monitoring over the general requirements for all medicines. Some may require short or medium specialist monitoring of efficacy or dose titration before transferring in Primary care. The GP should have all the information they require to support continued prescribing.   

Green Specialist Recomendation

  

Grey

Grey - Medicines, which the Drug & therapeutics Committee has actively reviewed and does not recommend for use at present following a review of clinical and/or cost effective data. Grey (assessment in progress) - will be reviewed at a future D&T meeting. Grey (awaiting submission) - The D&T are awaiting a submission from an appropriate practitioner. If you wish to make a submission for this medicine to be added to the formulary please email drug.information@bthft.nhs.uk .   

Non Formulary

Not recommended for prescribing as initial therapy, but can be continued if patient already stable on treatment   

Red

Medicines which should normally be prescribed by specialists only. ** For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care   

RED ULM

Unlicensed Medication  

netFormulary